e-learning
resources
Munich 2014
Sunday, 07.09.2014
Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of budesonide/formoterol on the airway transcriptome in COPD
Y. Gesthalter, K. Steiling, M. Lenburg, A. Spira, F. Schembri (Boston, United States Of America)
Source:
International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Session:
Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Session type:
Oral Presentation
Number:
400
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Gesthalter, K. Steiling, M. Lenburg, A. Spira, F. Schembri (Boston, United States Of America). The impact of budesonide/formoterol on the airway transcriptome in COPD. Eur Respir J 2014; 44: Suppl. 58, 400
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Combined analysis of gene expression and clinical data in the severe asthma U-BIOPRED cohorts
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Evaluation of inhalant deposition of ICS/LABA in the peripheral airway of asthma patients using Functional Respiratory Imaging (FRI)
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Gene set variation analysis of mRNA expression in bronchial biopsies from the U-BIOPRED asthma study
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Metabolomic profiling of the lung in a murine model of emphysema
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Whole transcriptome analysis in peripheral blood from asthmatic and healthy subjects in the U-BIOPRED study
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Airway surface dehydration is a novel risk factor for allergic airway inflammation
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Dynamics of cytokines in patients with severe asthma with extracorporeal immune lymphocytes modification
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Inflammation in COPD patients before and after roflumilast treatment
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014
Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Lung deposition of extrafine vs non-extrafine triple therapies in patients with COPD using Functional Respiratory Imaging (FRI).
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019
Lung deposition analysis of two formulations of fluticasone/salmeterol HFA pMDI in stable asthma patients
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Microarray analysis of long non-coding RNAs in COPD
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Effect of cold air on mucin secretion in the nasal mucosa in asthmatics
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Activin-A expression in COPD exacerbations: Local index of airway inflammation? Preliminary results
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Pathophysiology of asthma: From endotype to phenotype
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Effects of ICS/LABA treatment on hyperinflation and genome wide gene-expression in upper airway epithelium in severe COPD
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Multi-analyte profiling of inflammatory markers in COPD sputum
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Proteomic analysis of the airway inflammation in work related asthma
Source: International Congress 2014 – Occupational asthma: from childhood to adulthood
Year: 2014
Effects of treatment and withdrawal with inhaled beclomethasone/formoterol on electronic nose and NMR metabolomic breathprints in patients with COPD
Source: International Congress 2016 – Airway biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept